期刊文献+

异甘草素对人宫颈癌细胞增殖的抑制作用 被引量:17

Inhibitory effect of isoliquiritigenin on proliferation of human cervical cancer cells in vitro and in vivo
下载PDF
导出
摘要 目的鉴于异甘草素(ISL)对不同肿瘤细胞系的不同作用,研究ISL对人宫颈鳞状上皮癌细胞(CaSki)癌细胞的影响及有关机制.方法体外研究采用MTT法测定细胞增殖;流式细胞仪检测细胞周期;逆转录聚合酶链反应(RT-PCR)分析细胞周期蛋白B1(cyclin B1)mRNA表达;Western免疫印迹分析cyclin B1, P34cdc2和磷酸化P34cdc2(phospho-cdc2, 酪氨酸15)蛋白表达;体内研究通过建立人宫颈癌CaSki细胞裸鼠移植瘤模型观察抑瘤率.结果 ISL浓度依赖性(10~80 μmol·L-1)抑制CaSki细胞增殖,IC50为(19.3±3.3)μmol·L-1,且呈时间依赖性.ISL 20 μmol·L-1作用3 d对细胞抑制率为82.3%;ISL浓度依赖性(10~80 μmol·L-1)干扰CaSki细胞周期,细胞周期阻滞于S和G2/M期,S和G2/M期的百分率分别从23.1%和8.2%上升到43.2%和32.1%;同时G0/G1期细胞百分率从68.7%下降到24.7%;RT-PCR分析显示,ISL(10~80 μmol·L-1)显著抑制cyclin B1 mRNA表达,抑制率最高可达61.7%,且呈时间依赖性;Western免疫印迹分析显示,ISL作用24 h cyclin B1蛋白表达开始不同程度下降,48 h下降明显,P34cdc2变化较小,ISL作用16 h后磷酸化P34cdc2(酪氨酸15)蛋白水平明显改变;ISL(20~500 mg·kg-1·d-1)剂量依赖性抑制CaSki细胞裸鼠皮下移植瘤的生长,抑瘤率分别为36.8%,51.2%和84.6%,且对动物体重和外周血白细胞数均无明显影响.结论 ISL可以显著抑制人宫颈癌细胞体内外增殖,其机制与将细胞周期阻滞于S和G2/M期及影响细胞周期因子cyclin B1的表达和改变P34cdc2的磷酸化水平有关. AIM In view of the different effect of isoliquiritigenin(ISL) on proliferation of different tumors, to study the effect of ISL on proliferation of human cervical cancer cells in vitro and in vivo and its related mechanisms. METHODS Inhibitory effect of cell proliferation was evaluated by MTT method; cell cycle distributions were measured by flow cytometric assay; RT-PCR was used to analyze the expression of cyclin B1 mRNA; Western blotting analysis was used to detect the protein expression of cyclin B1 and phosphorylation change of P34^cac2. The inhibitory rate in vivo was evaluated in nude mice by means of human cervical cancer CaSki implantation. RE- SULTS ISL ( 10 - 80 μmol·L^-1 ) suppressed proliferation of human cervical cancer cells in a concentration- and time-dependent manner, the IC50 of CaSki cells exposed to ISL for 48 h was (19.3 - 3.3 ) μmol·L^-1, the inhibition rate of CaSki cells exposed to ISL ( 20 μmol·L^-1 ) Was 82. 3% on d 3 of culture. DNA flowcytometric analysis indicated that ISL induced the cell cycle arrest at S and G2/M phase concentration-depen-dently at 48 h. ISL down-regulated the expression of cyclin B1 mRNA, at the concentration of 80 μmol·L^-1 inhibitory rate reached the maximum (61.7%). Western blotting analysis showed that treatment of CaSki cells with ISL remarkably decreased the expression of cyclin B1 at 48h and enhanced the level of P34^cdc2 phosphorylation from 16 h; ISL was shown to inhibit human xenograft in nude mice with no apparent toxicity to the animals, the inhibition rate reached 84.6% at 500 mg·kg^-1·d^-1 for 10 d. CONCLUSION ISL can significantly inhibit proliferation of the human cervical cancer cells and induce cell cycle arrest at the S and G2/M phase, and this induction is associated with the influence on expression of cyclin B1 and phosphorylation of P34^cdc2 protein.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2005年第6期436-442,共7页 Chinese Journal of Pharmacology and Toxicology
基金 湖北省重点科技攻关项目(2004AA303B06)~~
关键词 异甘草素 细胞周期 宫颈肿瘤 细胞周期 isoliquiritigenin cell cycle cervix neoplasmas cyclin B
  • 相关文献

参考文献2

二级参考文献17

  • 1吴骏,朱家壁.阿昔洛韦脂质体的制备和稳定性的初步考察[J].药学学报,2003,38(7):552-554. 被引量:23
  • 2徐世荣 见:姚尔固 徐世荣 董作仁 主编.白血病化疗[A].见:姚尔固,徐世荣,董作仁,主编.新编白血病化疗学 第1版[C].天津:天津科学技术出版社,1999.71,82.
  • 3[1]Kanazawa M, Satomi Y, Mizutani Y, Ukimura O, Kawauchi A,Sakai T, et al. Isoliquiritigenin inhibits the growth of prostate cancer[J]. Eur Urol,2003;43 (5) :580- 6
  • 4[2]Vaya J, Belinky PA, Aviram M. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation[J]. Free Radic Biol Med, 1997;23(2) :302 - 13
  • 5[7]Ii T, Satomi Y, Katoh D, Shimada J, Baba M, Okuyama T, et al. Induction of cell cycle arrest and p21CIP1/WAF1 expression in human lung cancer cells by isoliquiritigenin[ J]. Cancer Lett,2004;207(1) :27 - 35
  • 6[8]Ma J, Fu NY, Pang DB, Wu WY, Xu AL. Apoptosis induced by isoliquiritigenin in human gastric cancer MGC-803 cells[ J].Planta Med, 2001 ;67(8) :754 - 7
  • 7[9]Wilson JK, Sargent JM, Elgie AW, Hill JG, Taylor CG. A feasibility study of the MTT assay for chemosensitivity testing in ovarian malignancy[J]. Br J Cancer, 1990;62(2): 189 - 94
  • 8[10]Gabizon A, Goren D, Barenholz Y. Investigations on the antitumor efficacy of liposome - associated doxorubicin in murine tumor models[J]. Isr J Med Sci, 1988; 24(9 - 10) :512 - 7
  • 9[11]Payne NI, Timmins P, Ambrose CV, Ward MD, Ridgway F.Proliposomes: a novel solution to an old problem[ J]. J Pharm Sci, 1986;75(4) :325 - 9
  • 10Malty A, Hwang A, Janss A, et al. Delayed cyclin B1 expression during the G2 arrest following DNA damage. Oncogene,1996,17:1647-1657.

共引文献25

同被引文献254

引证文献17

二级引证文献251

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部